Related references
Note: Only part of the references are listed.Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors
Goo-Young Kim et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Understanding the Physiology of FGF21
Ffolliott Martin Fisher et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)
Sirtuin regulation in aging and injury
Ninu Poulose et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Mutations leading to constitutive active gp130/JAK1/STAT3 pathway
Camilla Pilati et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Long-Term Administration of Fibroblast Growth Factor 21 Prevents Chemically-Induced Hepatocarcinogenesis in Mice
Pengfei Xu et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity
Goo-Young Kim et al.
HUMAN MOLECULAR GENETICS (2015)
Nitric oxide in liver diseases
Yasuko Iwakiri et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia
Young Mok Lee et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2015)
Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling
Andreas Herbst et al.
BMC GENOMICS (2014)
Hepatic SIRT1 Attenuates Hepatic Steatosis and Controls Energy Balance in Mice by Inducing Fibroblast Growth Factor 21
Yu Li et al.
GASTROENTEROLOGY (2014)
Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis
I-Chieh Chen et al.
MOLECULAR CANCER (2014)
Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer
Mousumi Tania et al.
TUMOR BIOLOGY (2014)
E-Cadherin and Gastric Cancer: Cause, Consequence, and Applications
Xin Liu et al.
BIOMED RESEARCH INTERNATIONAL (2014)
NAD+ metabolism: A therapeutic target for age-related metabolic disease
Laurent Mouchiroud et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease
Xia Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Wnt signaling and hepatocarcinogenesis: Molecular targets for the development of innovative anticancer drugs
Floriane Pez et al.
JOURNAL OF HEPATOLOGY (2013)
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2013)
Pharmacological activation of AMPK suppresses inflammatory response evoked by IL-6 signalling in mouse liver and in human hepatocytes
Annika Nerstedt et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
The upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in murine glycogen storage disease type Ia
Young Mok Lee et al.
MOLECULAR GENETICS AND METABOLISM (2013)
βKlotho Suppresses Tumor Growth in Hepatocellular Carcinoma by Regulating Akt/GSK-3β/Cyclin D1 Signaling Pathway
Xiaoming Ye et al.
PLOS ONE (2013)
Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism
Melanie Gertz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Modulating fibroblast growth factor 21 in hyperphagic OLETF rats with daily exercise and caloric restriction
Justin A. Fletcher et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM-PHYSIOLOGIE APPLIQUEE NUTRITION ET METABOLISME (2012)
Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy
Young Mok Lee et al.
HEPATOLOGY (2012)
Functional role of monocytes and macrophages for the inflammatory response in acute liver injury
Henning W. Zimmermann et al.
FRONTIERS IN PHYSIOLOGY (2012)
NF-kappa B and STAT3 - key players in liver inflammation and cancer
Guobin He et al.
CELL RESEARCH (2011)
AMP-activated protein kinase-an energy sensor that regulates all aspects of cell function
D. Grahame Hardie
GENES & DEVELOPMENT (2011)
AMPK and SIRT1: a long-standing partnership?
Neil B. Ruderman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy
Janice Y. Chou et al.
NATURE REVIEWS ENDOCRINOLOGY (2010)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1 - Possible role in AMP-activated protein kinase activation
Fan Lan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Impaired negative feedback suppression of bile acid synthesis in mice lacking βKlotho
S Ito et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Hepatocellular carcinoma in glycogen storage disease type Ia: A case series
LM Franco et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase
F Yeung et al.
EMBO JOURNAL (2004)
Share Paper
